Navigation Links
International Federation-Lilly Agreement Will Allow Significant Increase in MDR-TB Programmes
Date:11/29/2007

GENEVA, Nov. 29 /PRNewswire-FirstCall/ -- The International Federation of Red Cross and Red Crescent Societies and Eli Lilly and Company, a multi- national pharmaceutical company, signed an agreement which will allow an eight-fold increase in the number of International Federation-supported programmes to fight multidrug-resistant tuberculosis (MDR-TB) over the next four years.

Lilly's 1.6 million USD contribution will finance programmes between 2008 and 2011. In 2008 alone, the International Federation will expand its support to 10 additional MDR-TB programmes in Kazakhstan, Uzbekistan, Romania, Georgia, Kenya, Mozambique and South Africa, for a total of 14 MDR-TB programmes.

"It is vital that tuberculosis patients complete their treatment, both to be cured, and to avoid a relapse into the more serious form of the disease, called multidrug-resistant TB, which is much more expensive and difficult to treat," explains Markku Niskala, secretary general of the International Federation. "We have noticed an increase of MDR-TB in certain regions, and it is essential we expand our programmes to help curb this trend. The Lilly funds will allow us to do that."

The first phase of the International Federation and Lilly MDR-TB Programme was implemented from 2004 to 2007 in three pilot countries. "Based on the success of the current programmes in Kazakhstan, Romania and Uzbekistan, we embrace the challenge of expanding this programme to cover more than ten countries," says Sidney Taurel, chairman and CEO of Lilly.

"These activities join those of a larger partnership of 14 public and private organisations around the world committed to fighting MDR-TB from every angle. We will continue to learn lessons from existing programmes and improve our initiatives to best serve those suffering from MDR-TB, and to best prevent its spread. We are committed, for the long-term, to triumph over the re-emergence of TB and MDR-TB."

Red Cross and Red Crescent
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. International study strengthens case for daily calcium pill
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
4. LCA Hails International Investigators Studying Lung Cancer
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. PRA International Adds Dr. Susan Stansfield as Executive Vice President
7. Medical Services International Maintains Pace in Second Quarter
8. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
9. International Gateway Insurance Brokers Partners With MEDILINQ
10. Tulane University to receive $14M for international HIV/AIDS program
11. International Database Seeks to Boost Treatment of Altitude Sickness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... Parker Waichman LLP , a ... victims injured by defective medical devices, notes that Johnson ... a May 16, 2013, statement that it ... hip replacement products; specifically, the metal liners in the ... System will no longer be available worldwide after Aug. ...
(Date:5/17/2013)... HealthDay Reporter , , FRIDAY, May 17 (HealthDay News) -- There ... a musical instrument and a GPS system, and now there,s ... you,re having a heart attack. The app, which was ... diagnose certain kinds of severe heart attacks, called STEMIs, before ... in the experimental stage, but it has undergone field testing. ...
(Date:5/17/2013)... Fighting addiction is hard enough for ... treatment is more difficult and complicated. Drug and alcohol ... blood sugar levels and administer insulin when necessary. To ... rehab for diabetics needs to have expert staff ... the diabetic, and has experience caring for them. Diabetes ...
(Date:5/17/2013)... 17 (HealthDay News) -- Although being openly gay ... it does not affect views on his performance, ... from Clemson University in South Carolina found that ... when playing a heterosexual role, despite stereotypes about ... to perceive a direct connection between sexual orientation ...
(Date:5/17/2013)... Liver transplants to treat a common type of liver ... HIV, according to new research. The Italian study, ... , found that the AIDS-causing virus doesn,t affect survival ... with this particular type of liver cancer, called hepatocellular ... is more aggressive in people with HIV and it ...
Breaking Medicine News(10 mins):Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 2Health News:Parker Waichman LLP Responds to Johnson & Johnson’s Decision to Discontinue Some of Its DePuy All-metal and Ceramic-on-metal Hip Implant Products 3Health News:Heart Attack? Doctors Soon May Have an App for That 2Health News:Heart Attack? Doctors Soon May Have an App for That 3Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 2Health News:Above It All Treatment Center Helps Drug Addicts who are Type I and Type II Diabetics 3Health News:Gay Actors Convincing in Heterosexual Roles 2Health News:HIV No Barrier to Getting Liver Transplant, Study Finds 2
... ... awake breast augmentation. This new cosmetic procure allows for breast augmentation without general anesthesia. ... ... York Times discussed a relatively new technique for augmenting breasts called Awake Breast Aug. Jane ...
... ... The Army has selected DOMA Technologies to provide Medical ... provide Business-To-Business remote coding services using their iCodeRx SaaS application and ... team will code, abstract, analyze and assemble medical record data and ...
... folks process input differently , SATURDAY, April 10 ... around them in a different way, introverted or shy ... other people, according to a new study. , About ... trait that can be seen in children who are ...
... ... of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis for 25,000 patients with nebulized ... ... in Westlake Village, California, is very proud to announce that it has reached an ...
... ... ... Arizona School of Health Sciences (ATSU-ASHS) held its spring commencement ceremony for four online ... a master of science or doctoral degree in Human Movement, Physician Assistant Studies, Audiology, and ...
... Researchers from the Children,s Cancer Hospital at The University ... a way to more accurately predict treatment outcomes in young ... blood count test, also known as a CBC. ... American Society of Pediatric Hematology Oncology,s (ASPHO) annual meeting today. ...
Cached Medicine News:Health News:Dr. Robert True Responds to a New York Time Article About a New Cosmetic Procedure Called Awake Breast Augmentation 2Health News:Army Awards Remote Medical Coding Contract to DOMA Technologies 2Health News:Shyness May Be Rooted in Brain Processing 2Health News:Sinus Dynamics Reaches Milestone with Treatment of Nasal Allergy, Sinus Infection, Acute and Chronic Sinusitis Treating 25,000th Patient 2Health News:ATSU –ASHS Holds Spring Commencement Ceremony 2Health News:M. D. Anderson zeroes in on better way to predict prognosis in pediatric leukemia patients 2
(Date:5/17/2013)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... systems, announced today that the United States Food and ... Drug application(IND) for ORMD-0801, its oral insulin capsule. ... clearance to proceed," stated Nadav Kidron ... major milestone for Oramed and we look forward to ...
(Date:5/16/2013)... N.J. , May 16, 2013  PTC Therapeutics, ... statement on Form S-1 with the U.S. Securities and ... offering of its common stock. The number of shares ... offering have not been determined. (Logo:  ... Suisse are acting as joint book-running managers for the ...
(Date:5/16/2013)...  Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
... Healthcare Products Association (CHPA) today applauded the Alabama ... bill that significantly improves Alabama,s methamphetamine enforcement laws ... for meth-related crime and enhancements to the state,s ... called the National Precursor Log Exchange (NPLEx), successfully ...
... Colo., April 20, 2012  Results from the combined ... presented today at the 3rd European Lung Cancer ... was performed on serum samples from advanced non-squamous ... the combination therapy bevacizumab plus erlotinib.  Results showed ...
Cached Medicine Technology:CHPA Applauds Alabama Senate's Passage of Anti-Meth Bill 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 3
Patient-Centered Therapy that promotes natural cardiac function....
... The Alliance Catheter Delivery ... manipulation, and stabilization of the ... Alliance CDS has a patented ... for quick and easy access ...
... throughout the world are facing difficult times ... of the blood supply in the face ... donor base. Clearly, these centers must find ... manage their existing donor pools, and to ...
The COBE 2991 Cell Processor provides reliable, automated cell processing, with the control you need to get reproducible results in your lab. This versatile machine offers users reliability and multi...
Medicine Products: